Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1983 Sep;198(3):273–283. doi: 10.1097/00000658-198309000-00004

Portacaval shunt in patients with familial hypercholesterolemia.

T E Starzl, H P Chase, E H Ahrens Jr, D J McNamara, D W Bilheimer, E J Schaefer, J Rey, K A Porter, E Stein, A Francavilla, L N Benson
PMCID: PMC1353292  PMID: 6615051

Abstract

Portacaval shunt was performed in ten patients with homozygous and two with heterozygous familial hypercholesterolemia (FH). Total serum cholesterol was lowered by 20% to 55.4% during follow-up periods of 14 months to almost 9 years, with commensurate decreases in LDL cholesterol. The effect on HDL cholesterol and triglyceride levels was variable. Tendinocutaneous xanthomas diminished or disappeared. Growth and development in children proceeded or accelerated. There was no detectable emotional or intellectual deterioration. Hepatic failure did not occur, although blood ammonia concentrations and serum alkaline phosphatase levels increased relative to preoperative values. Cardiac symptoms were often improved, but evidence of reversal of cardiovascular lesions was inconclusive. Three patients with pre-existing heart disease died of cardiac complications after 4 months, 18 1/2 months, and 30 months. Portacaval shunt has been effective therapy for patients with FH who were refractory or intolerant to medical treatment; it should be performed before the development of irreversible cardiovascular damage.

Full text

PDF
273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
  2. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  3. Andersen J. M., Nervi F. O., Dietschy J. M. Rate constants for the uptake of cholesterol from various intestinal and serum lipoprotein fractions by the liver of the rat in vivo. Biochim Biophys Acta. 1977 Feb 23;486(2):298–307. doi: 10.1016/0005-2760(77)90025-x. [DOI] [PubMed] [Google Scholar]
  4. Baker S. G., Joffe B. I., Mendelsohn D., Seftel H. C. Treatment of homozygous familial hypercholesterolaemia with probucol. S Afr Med J. 1982 Jul 3;62(1):7–11. [PubMed] [Google Scholar]
  5. Balasubramaniam S., Press C. M., Mitropoulos K. A., Magide A. A., Myant N. B. Effect of portacaval anastomosis on the activities of hepatic enzymes related to cholesterol and bile acid metabolism in rats. Biochim Biophys Acta. 1976 Aug 23;441(2):308–315. doi: 10.1016/0005-2760(76)90174-0. [DOI] [PubMed] [Google Scholar]
  6. Bilheimer D. W., Goldstein J. L., Grundy S. M., Brown M. S. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest. 1975 Dec;56(6):1420–1430. doi: 10.1172/JCI108223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Blanchard H., Bensoussan A. L., Collin P. P., Desjardins J. G., Ouimet A., Letarte J. L'anastomose porto-cave termino-latérale dans l'hypercholestérolémie familiae de type II homozygote. Chir Pediatr. 1979;20(3):221–226. [PubMed] [Google Scholar]
  8. Buchwald H., Moore R. B., Varco R. L. Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias. Ann Surg. 1974 Oct;180(4):384–392. doi: 10.1097/00000658-197410000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carew T. E., Saik R. P., Johansen K. H., Dennis C. A., Steinberg D. Low density and high density lipoprotein turnover following portacaval shunt in swine. J Lipid Res. 1976 Sep;17(5):441–450. [PubMed] [Google Scholar]
  10. Chase H. P., Morris T. Cholesterol metabolism following portacaval shunt in the pig. Atherosclerosis. 1976 Jul-Aug;24(1-2):141–148. doi: 10.1016/0021-9150(76)90071-x. [DOI] [PubMed] [Google Scholar]
  11. Coyle J. J., Schwartz M. Z., Marubbio A. T., Varco R. L., Buchwald H. The effect of portacaval shunt on plasma lipids and tissue cholesterol synthesis in the dog. Surgery. 1976 Jul;80(1):54–60. [PubMed] [Google Scholar]
  12. Cywes S., Davies M. R., Louw J. H., Berger G. M., Bonnici F., Joffe H. S. Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia. S Afr Med J. 1976 Feb 21;50(8):239–243. [PubMed] [Google Scholar]
  13. Faergeman O., Gormsen J., Meinertz H. Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia. Lancet. 1976 Dec 25;2(8000):1416–1416. doi: 10.1016/s0140-6736(76)91962-0. [DOI] [PubMed] [Google Scholar]
  14. Farriaux J. P., Bertrand M., Ribet M. Hypercholesterolemia, portacaval shunt and coronary disease. N Engl J Med. 1979 Jul 12;301(2):108–108. doi: 10.1056/NEJM197907123010215. [DOI] [PubMed] [Google Scholar]
  15. Farriaux J. P., Ribet M., Bertrand M., Higgins M., Mazzuca M., Luyckx A. Traitement de l'hypercholestérolémie familiale de type II par shunt porto-cave. Arch Fr Pediatr. 1976 Oct;33(8):745–759. [PubMed] [Google Scholar]
  16. Fonkalsrud E. W., Myers N. A., Robinson M. J. Management of extrahepatic portal hypertension in children. Ann Surg. 1974 Oct;180(4):487–493. doi: 10.1097/00000658-197410000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Forman M. B., Baker S. G., Mieny C. J., Joffe B. I., Sandler M. P., Mendelsohn D. U., Seftel H. C. Treatment of homozygous familial hypercholesterolaemia with portacaval shunt. Atherosclerosis. 1982 Feb;41(2-3):349–361. doi: 10.1016/0021-9150(82)90199-x. [DOI] [PubMed] [Google Scholar]
  18. Francavilla A., Jones A. F., Benichou J., Starzl T. E. The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons. J Surg Res. 1980 Jan;28(1):1–7. doi: 10.1016/0022-4804(80)90074-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ginsberg H., Davidson N., Le N. A., Gibson J., Ahrens E. H., Jr, Brown W. V. Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting. Biochim Biophys Acta. 1982 Aug 18;712(2):250–257. doi: 10.1016/0005-2760(82)90341-1. [DOI] [PubMed] [Google Scholar]
  20. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  21. Goldstein J. L., Dana S. E., Brunschede G. Y., Brown M. S. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. Proc Natl Acad Sci U S A. 1975 Mar;72(3):1092–1096. doi: 10.1073/pnas.72.3.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Guzman I. J., Coyle J. J., Schneider P. D., Varco R. L., Buchwald H. The effect of selective visceral caval shunt on plasma lipids and cholesterol dynamics. Surgery. 1977 Jul;82(1):42–50. [PubMed] [Google Scholar]
  23. Guzman I. J., Schneider P. D., Coyle J. J., Varco R. L., Buchwald H. Combined hypolipidemia of portacaval transposition and ileal resection in the dog. Surg Gynecol Obstet. 1980 Apr;150(4):475–480. [PubMed] [Google Scholar]
  24. Horak W., Gangl A., Funovics J., Grabner G. Effect of portacaval shunt and arterialization of the liver on bile acid metabolism. Gastroenterology. 1975 Aug;69(2):338–341. [PubMed] [Google Scholar]
  25. James J. H., Soeters P. B., Escourrou J., Fischer J. E. Decreased cholesterol and fatty acid synthesis following portacaval shunt. Surg Forum. 1977;28:397–399. [PubMed] [Google Scholar]
  26. Kovanen P. T., Bilheimer D. W., Goldstein J. L., Jaramillo J. J., Brown M. S. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1194–1198. doi: 10.1073/pnas.78.2.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Krogh L., Wickens J. T. Letter: Portocaval shunt for hypercholesterolaemia. S Afr Med J. 1974 Nov 16;48(56):2302–2302. [PubMed] [Google Scholar]
  28. Lauterburg B., Sautter V., Herz R., Colombo J. P., Roch-Ramel F., Bircher J. The defect of uric acid metabolism in Eck-fistula rats. J Lab Clin Med. 1977 Jul;90(1):92–100. [PubMed] [Google Scholar]
  29. Madras P. N. Portacaval shunt for familial heterozygous hypercholesterolemia. Surg Gynecol Obstet. 1981 Feb;152(2):187–190. [PubMed] [Google Scholar]
  30. Nestruck A. C., Bergseth M., Bidallier M., Davignon J., Marcel Y. L. Lipid and lipoprotein secretion following portacaval shunt in swine. Atherosclerosis. 1978 Mar;29(3):355–362. doi: 10.1016/0021-9150(78)90082-5. [DOI] [PubMed] [Google Scholar]
  31. Parks J. S., Lehner N. D., St Clair R. W., Lofland H. B. Portacaval shunt and whole-body cholesterol metabolism in the cholesterol-fed African green monkey. Proc Soc Exp Biol Med. 1979 Sep;161(4):502–507. doi: 10.3181/00379727-161-40583. [DOI] [PubMed] [Google Scholar]
  32. Proia A., McNamara D. J., Edwards K. D., Ahrens E. H., Jr Cholesterol homeostasis in the rat with a portacaval anastomosis. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4654–4657. doi: 10.1073/pnas.76.9.4654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Putnam C. W., Porter K. A., Starzl T. E. Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg. 1976 Aug;184(2):155–161. doi: 10.1097/00000658-197608000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rossouw J. E., Labadarios D., de Villiers A. S. Plasma lipids and hepatic lipid synthesis following portacaval shunt in the rat. S Afr Med J. 1978 Jun 17;53(25):1024–1026. [PubMed] [Google Scholar]
  35. Shurberg J. L., Resnick R. H., Koff R. S., Ros E., Baum R. A., Pallotta J. A. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis. Gastroenterology. 1977 Feb;72(2):301–304. [PubMed] [Google Scholar]
  36. Small D. M., Shipley G. G. Physical-chemical basis of lipid deposition in atherosclerosis. Science. 1974 Jul 19;185(4147):222–229. doi: 10.1126/science.185.4147.222. [DOI] [PubMed] [Google Scholar]
  37. Soutar A. K., Myant N. B., Thompson G. R. Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis. 1977 Nov;28(3):247–256. doi: 10.1016/0021-9150(77)90174-5. [DOI] [PubMed] [Google Scholar]
  38. Starzl T. E., Chase H. P., Putnam C. W., Nora J. J., Fennell R. H., Jr, Porter K. A. Letter: Portacaval shunt in hyperlipidaemia. Lancet. 1974 Nov 23;2(7891):1263–1263. doi: 10.1016/s0140-6736(74)90774-0. [DOI] [PubMed] [Google Scholar]
  39. Starzl T. E., Chase H. P., Putnam C. W., Nora J. J. Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia. Lancet. 1974 Sep 21;2(7882):714–715. doi: 10.1016/s0140-6736(74)93285-1. [DOI] [PubMed] [Google Scholar]
  40. Starzl T. E., Francavilla A., Halgrimson C. G., Francavilla F. R., Porter K. A., Brown T. H., Putnam C. W. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet. 1973 Aug;137(2):179–199. [PMC free article] [PubMed] [Google Scholar]
  41. Starzl T. E., Iwatsuki S., Van Thiel D. H., Gartner J. C., Zitelli B. J., Malatack J. J., Schade R. R., Shaw B. W., Jr, Hakala T. R., Rosenthal J. T. Evolution of liver transplantation. Hepatology. 1982 Sep-Oct;2(5):614–636. doi: 10.1002/hep.1840020516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Starzl T. E., Putnam C. W., Chase H. P., Porter K. A. Portacaval shunt in hyperlipoproteinaemia. Lancet. 1973 Oct 27;2(7835):940–944. doi: 10.1016/s0140-6736(73)92599-3. [DOI] [PubMed] [Google Scholar]
  43. Starzl T. E., Putnam C. W., Porter K. A., Halgrimson C. G., Corman J., Brown B. I., Gotlin R. W., Rodgerson D. O., Greene H. L. Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg. 1973 Oct;178(4):525–539. doi: 10.1097/00000658-197310000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Starzl T. E., Terblanche J. Hepatotrophic substances. Prog Liver Dis. 1979;6:135–151. [PubMed] [Google Scholar]
  45. Stein E. A., Pettifor J., Mieny C., Heimann K. W., Spitz L., Bersohn I., Saaron I., Dinner M. Portacaval shunt in four patients with homozygous hypercholesterolaemia. Lancet. 1975 Apr 12;1(7911):832–835. doi: 10.1016/s0140-6736(75)93005-6. [DOI] [PubMed] [Google Scholar]
  46. Van't Hooft F. M., Hardman D. A., Kane J. P., Havel R. J. Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the apolipoprotein of low density lipoproteins. Proc Natl Acad Sci U S A. 1982 Jan;79(1):179–182. doi: 10.1073/pnas.79.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Voorhees A. B., Jr, Chaitman E., Schneider S., Nicholson J. F., Kornfeld S., Price J. B., Jr Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting. Arch Surg. 1973 Nov;107(5):659–663. doi: 10.1001/archsurg.1973.01350230017005. [DOI] [PubMed] [Google Scholar]
  48. Weglicki W. B., Ganda O. P., Soeldner J. S., Murawski B. J., Cohn L. H., Couch N. P. Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin, and glucagon levels. Arch Surg. 1977 May;112(5):634–636. doi: 10.1001/archsurg.1977.01370050094016. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES